LINDSEY BENDER: Open Payments
NPI 1649958703 · IMPERIAL, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 20 payments from 12 companies in 2025. Trend: 2023 $20 · 2024 $184 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $73 |
| Exact Sciences Corporation | 3 | $53 |
| Lilly USA, LLC | 2 | $45 |
| Amgen Inc. | 2 | $36 |
| Currax Pharmaceuticals LLC | 2 | $33 |
| ABBVIE INC. | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
Products named: MOUNJARO, Wegovy, Cologuard Collection Kit, CONTRAVE, UBRELVY, ELIQUIS, EVENITY, SHINGRIX.
Industry payments across MO — which companies pay providers there.
